Pharmadrug Inc.
PHRX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.40K | 5.40K | 23.60K | -14.60K | 23.20K |
| Depreciation & Amortization | 9.10K | 9.10K | 8.80K | 9.00K | 9.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.50K | 14.50K | 32.40K | 64.20K | 37.10K |
| Operating Income | -19.50K | -14.50K | -32.40K | -64.20K | -37.10K |
| Income Before Tax | -63.30K | -61.30K | -81.60K | -5.00K | -132.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.30K | -61.30K | -81.60K | -5.00K | -132.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.20K | 8.80K | 11.80K | 57.10K | 7.10K |
| Net Income | -56.00K | -52.50K | -69.80K | 52.00K | -125.60K |
| EBIT | -19.50K | -14.50K | -32.40K | -64.20K | -37.10K |
| EBITDA | -10.40K | -5.40K | -23.60K | -55.20K | -27.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 108.23M | 108.23M | 107.77M | 107.76M | 104.14M |
| Average Diluted Shares Outstanding | 108.23M | 108.23M | 107.77M | 107.76M | 104.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |